Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Find news

All 400 news items, newest first.

Newest first by default, because news is about what is current. 51 items link to a study summarized in alzhub's library, because the article itself cites that paper.

Free to read, “May need a subscription” and “Archived copy”: what they mean

Whether an article is free to read is a guess, not a test of your access. Each item is one of three:

  • No label: free to read (341 of 400). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
  • May need a subscription (15 of 400). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
  • “Free to read? Not known” (44 of 400). The outlet is on neither list and its page said nothing. We do not call these paywalled.

Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 288 of 400 items have one.

Alzheimer's Test Results Delivered Digitally Didn't Increase Distress

MedPage Today Diagnosis

(MedPage Today) -- Getting Alzheimer's genetic and biomarker results through a digital tool was noninferior to receiving the information during a telehealth appointment, the randomized eSMARTER trial showed. One to 7 days after APOE results were...

Free to read? Not known for this outlet.

Read at MedPage Today →

Could an erectile dysfunction drug offer a new way to treat Alzheimer's?

Medical Xpress Research

A drug developed to treat erectile dysfunction might seem an unlikely treatment for Alzheimer's disease. But researchers are increasingly interested in whether medicines such as Viagra could also help protect the brain.

Read at Medical Xpress →

A protein in the brain's immune cells may accelerate damage in Alzheimer's disease

Medical Xpress Research

Researchers at Lund University in Sweden have identified a key role for the protein galectin-3 in Alzheimer's disease. The study shows that galectin-3 not only influences how the brain's immune cells, known as microglia…

Read at Medical Xpress →

Resistance training could help boost brain health and confidence in older adults

Medical Xpress

Think about the last time you stood up from a chair or lifted a heavy shopping bag from the floor. These movements might feel automatic, but they take a surprising amount of coordination between your brain and your muscles.

Read at Medical Xpress →

Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial

MedPage Today Research

(MedPage Today) -- A novel Alzheimer's therapy platform that delivered 40 Hz light and sound stimulation to engage gamma-frequency brain activity did not meet its primary endpoint, the HOPE pivotal study showed. In the primary analysis population...

Free to read? Not known for this outlet.

Read at MedPage Today →

Improved blood test offers less invasive way to detect Alzheimer's disease

Medical Xpress Diagnosis

A new study in Nature Aging from Lund University in Sweden shows that improved blood tests for the diagnosis of Alzheimer's disease can now be used with accuracy similar to that of the cerebrospinal fluid tests that have long been the standard in health care. …

Read at Medical Xpress →

The surprising cancer connection at the heart of Alzheimer's

Medical Xpress

People say "the body keeps score"—but it might be more accurate to say our neurons do. In healthy people, neurons accumulate about 17 single-nucleotide variants each year, a pattern that holds from birth through a person's final years…

Read at Medical Xpress →

Genetics can make a 10-year difference in the onset of Alzheimer's disease

Medical Xpress

Why do some people develop Alzheimer's disease much earlier than others, even when they share the same genetic alteration that causes the disease? …

Read at Medical Xpress →

Blood Test May Detect CTE During Life, Study Shows

MedPage Today Diagnosis

(MedPage Today) -- Detecting chronic traumatic encephalopathy (CTE) in living patients may soon be possible, according to preliminary data from a case series. CTE, a neurodegenerative disease associated with repetitive head impacts from contact...

Free to read? Not known for this outlet.

Read at MedPage Today →

Your brain may be hiding Alzheimer's from you—and that's not always a good thing

Medical Xpress Research

When scientists examine the brains of older people after death, what they find can often be puzzling. One such puzzle is that around a third of people who showed no signs of dementia when they were alive had brains that contained key indicators of Alzheimer's disease.

Read at Medical Xpress →

Targeting immune overactivity in Down syndrome shows promise in phase 2 clinical trial

Medical Xpress Research

In a first-of-its-kind clinical trial, researchers at the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz found that a medication targeting immune overactivity in people with Down syndrome reduced underlying inflammation…

Read at Medical Xpress →

Brain model offers new explanation for memory formation and how dementia disrupts it

Medical Xpress Research

A new framework, published in Brain, could reshape researchers' understanding of how the brain creates memories and experiences, and how disruptions in this process may indicate Alzheimer's disease and other forms of dementia.

Read at Medical Xpress →

How poetry can offer a vital, humane response to dementia

Medical Xpress Caregiving

I'm sitting in the lounge of a Midlands nursing home on a hazy September morning. Most of the residents here have dementia and, as in many care and nursing homes, they lack meaningful ways to spend their time.

Read at Medical Xpress →

People with certain herpes infections have almost 50% higher risk of Alzheimer's or dementia, review finds

Medical Xpress

Being infected with herpes simplex virus type 1 (HSV-1) is associated with a 48% increase in the risk of Alzheimer's disease or other types of dementia, according to a meta-analysis published in Open Forum Infectious Diseases.

Read at Medical Xpress →

The hypothalamus is not a bystander in Alzheimer's disease

Medical Xpress

Alzheimer's disease is well known as a disease of memory. But long before memory fades, many patients have trouble sleeping, lose their daily rhythms and show changes in metabolism and stress hormones. …

Read at Medical Xpress →

Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial

Medical Xpress Research

At the Clinical Trials on Alzheimer's Disease conference in Boston Nov. 16, MIT spinoff company Cognito Therapeutics announced the results of its pivotal clinical trial of a noninvasive…

Read at Medical Xpress →

Inspired by 'Flowers for Algernon,' experimental nose drops improve memory in mice

Medical Xpress Research

Researchers at the University of Sydney have developed experimental nose drops that enhance learning and memory in aged mice while also preventing memory loss in a mouse model of Alzheimer's disease. …

Read at Medical Xpress →

FDA approves drug for infantile-onset Niemann-Pick type C after analysis finds longer survival

Medical Xpress Drug approvals

Researchers at the National Institutes of Health (NIH) and their collaborators at Beren Therapeutics, Thousand Oaks, California, have developed a treatment for infants with Niemann-Pick type C (NPC) disease…

Read at Medical Xpress →

A little-known protein could be a powerful weapon against Alzheimer’s

ScienceDaily Research

Scientists have uncovered a powerful natural defense against Alzheimer’s disease that could open the door to new treatments. By boosting a protein called SORLA, researchers significantly reduced toxic tau tangles, protected connections between brain cells…

Read at ScienceDaily → Archived copy (18 Nov 2026), Internet Archive

MIT discovers that aging weakens the brain’s nighttime cleaning system

ScienceDaily Research

MIT researchers have discovered that the brain’s natural waste-removal system becomes significantly less effective during sleep as people age. …

Read at ScienceDaily → Archived copy (18 Nov 2026), Internet Archive

Tau Therapy Shows Continued Benefit at 2 Years in Alzheimer's

MedPage Today Research

(MedPage Today) -- Diranersen, an investigational antisense oligonucleotide therapy that targets tau, continued to show benefits for 96 weeks, data from the open-label extension of the phase II CELIA trial suggested. At 2 years, diranersen continued...

Free to read? Not known for this outlet.

Read at MedPage Today →

Alzheimer's disease protein atlas reveals hidden cell-type biology

Medical Xpress Research

Alzheimer's disease can affect almost the entire brain, but how different cell types are specifically affected is not fully understood. To address this gap, St. Jude Children's Research Hospital scientists developed a cell type…

Read at Medical Xpress →

Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead

Medical Xpress Diagnosis

A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.

Read at Medical Xpress →

Experimental blood test can detect four signs of deadly diseases in an hour

Medical Xpress Diagnosis

A new diagnostic platform is able to screen for and identify four different diseases—colorectal cancer, glioblastoma, pancreatic cancer and Alzheimer's disease—with a small amount of blood in an hour. …

Read at Medical Xpress →

Understanding how inflammation begins so scientists can end it

Medical Xpress Research

Chronic inflammation is a major factor in arthritis, type 2 diabetes, Alzheimer's disease and cancer. A new tool developed at UC Riverside allows researchers to see exactly how inflammation begins in human cells. …

Read at Medical Xpress →

Bridging the gap between genetic variation and function in brain cells

Medical Xpress

Research has started to bridge the gap between identifying genetic changes that can increase the risk of brain conditions, such as Alzheimer's, and understanding how they might impact specific cell functions.

Read at Medical Xpress →

Chronic loneliness increases dementia risk by 38%, but occasional loneliness appears harmless, 30-year study finds

Medical Xpress Research

A new study that tracked people over the course of 30 years finds that only chronic, persistent loneliness is strongly linked with dementia.

Read at Medical Xpress →

Younger generations appear to have a double advantage against dementia, researchers find

Medical Xpress Research

Anders Fjell is the lead author of a new study that was just published in the journal Nature Medicine titled "Generational gains in cognitive capacity and dementia incidence rates in Western countries." …

Read at Medical Xpress →

Erectile Dysfunction Drug Shows Mixed Results in Alzheimer's

MedPage Today Research

(MedPage Today) -- Mirodenafil (known as AR1001), an oral phosphodiesterase-5 inhibitor approved in South Korea to treat erectile dysfunction, showed mixed results in people with early Alzheimer's disease in the phase III POLARIS-AD trial. The...

Free to read? Not known for this outlet.

Read at MedPage Today →

Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted

MedPage Today Diagnosis

(MedPage Today) -- In a cohort of cognitively unimpaired individuals, blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of developing mild cognitive impairment and dementia. (JAMA Neurology) Waves of cerebrospinal...

Free to read? Not known for this outlet.

Read at MedPage Today → Archived copy (18 Nov 2026), Internet Archive

What the research library says

Each page below is built from the studies in alzhub's library: how many match, what kinds of study they are, and what the papers report in their own words.

Last updated